alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>
                                                                   EXHIBIT 32.1


                            CERTIFICATION PURSUANT TO
                 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Annual Report on Form 10-K of Northern Border
Pipeline Company (the "Partnership") for the annual period ended December 31,
2003 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), William R. Cordes, as President of Northern Plains Natural Gas
Company (the "Operator"), hereby certifies, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1) The Report fully complies with the requirements of section 13(a) or
section 15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Partnership.


 Dated:  March 12, 2004          /s/ William R. Cordes
                                 -----------------------------------
                                 William R. Cordes
                                 President
                                 Northern Plains Natural Gas Company

This certification is made solely for the purpose of 18 U.S.C. Section 1350, and
not for any other purpose.
[Federal Register Volume 70, Number 212 (Thursday, November 3, 2005)]
[Notices]
[Pages 66847-66848]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-21948]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigations Nos. 731-TA-308-310, 520, and 521 (Second Review)]


Carbon Steel Butt-Weld Pipe Fittings From Brazil, China, Japan, 
Taiwan, and Thailand

Determinations

    On the basis of the record \1\ developed in these subject five-year 
reviews, the United States International Trade Commission (Commission) 
determines,\2\ pursuant to section 751(c) of the Tariff Act of 1930 (19 
U.S.C. 1675(c)) (the Act), that revocation of the antidumping duty 
orders on carbon steel butt-weld pipe fittings from Brazil, China, 
Japan, Taiwan, and Thailand would be likely to lead to continuation or 
recurrence of material injury to an industry in the United States 
within a reasonably foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
    \2\ Commissioner Shara L. Aranoff did not participate in these 
reviews.
---------------------------------------------------------------------------

Background

    The Commission instituted these reviews on December 1, 2004 (69 FR 
69952) and determined on March 7, 2005 that it would conduct full 
reviews (70 FR 14713, March 23, 2005). Notice of the scheduling of the 
Commission's reviews and of a public hearing to be held in connection 
therewith was given by posting copies of the notice in the Office of 
the Secretary, U.S. International Trade Commission, Washington, DC, and 
by publishing the

[[Page 66848]]

notice in the Federal Register on May 11, 2005 (70 FR 24838). The 
hearing was held in Washington, DC, on September 7, 2005, and all 
persons who requested the opportunity were permitted to appear in 
person or by counsel.
    The Commission transmitted its determinations in these reviews to 
the Secretary of Commerce on October 31, 2005. The views of the 
Commission are contained in USITC Publication 3809 (October 2005), 
entitled Carbon Steel Butt-Weld Pipe Fittings from Brazil, China, 
Japan, Taiwan, and Thailand: Investigation Nos. 731-TA-308-310, 520, 
and 521 (Second Review).

    By order of the Commission.

    Issued: October 31, 2005.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 05-21948 Filed 11-2-05; 8:45 am]
BILLING CODE 7020-02-P
|                                               |
|-----------------------------------------------|
| EXHIBIT 13.1                                  |
|                                          |
| CERTIFICATION OF                              |
| CHIEF EXECUTIVE OFFICER                       |
| PURSUANT TO                                   |
| 18 U.S.C. SECTION 1350,                       |
| AS ADOPTED PURSUANT TO                        |
| SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 |

I, Dr. Declan Doogan, Chief Executive Officer of Portage Biotech Inc. (the “Company”), hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge: 

(i) the Annual Report on Form 20-F of the Company for the fiscal year ended March 31, 2016 (the “Annual Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

(ii) the information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

| Date: 

July 27, 2016

 

 

  

/s/ Declan Doogan

By: 

Dr. Declan Doogan 

Title: 

Chief Executive Officer 

*This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Company’s Annual Report on Form 20-F. A signed original of this statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.*

*This certification accompanies this Annual Report on Form 20-F pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.* |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
Case 1:07-cv-03397-JGK Document 11 Filed 06/13/2007 Page 1 of 8
Case 1:07-cv-03397-JGK Document 11 Filed 06/13/2007 Page 2 of 8
Case 1:07-cv-03397-JGK Document 11 Filed 06/13/2007 Page 3 of 8
Case 1:07-cv-03397-JGK Document 11 Filed 06/13/2007 Page 4 of 8
Case 1:07-cv-03397-JGK Document 11 Filed 06/13/2007 Page 5 of 8
Case 1:07-cv-03397-JGK Document 11 Filed 06/13/2007 Page 6 of 8
Case 1:07-cv-03397-JGK Document 11 Filed 06/13/2007 Page 7 of 8
Case 1:07-cv-03397-JGK Document 11 Filed 06/13/2007 Page 8 of 8
[Federal Register Volume 70, Number 229 (Wednesday, November 30, 2005)]
[Notices]
[Pages 71866-71867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-23475]


=======================================================================
-----------------------------------------------------------------------

RAILROAD RETIREMENT BOARD


Agency Forms Submitted for OMB Review

    Summary: In accordance with the Paperwork Reduction Act of 1995 (44 
U.S.C. Chapter 35), the Railroad Retirement Board (RRB) has submitted 
the following proposal(s) for the

[[Page 71867]]

collection of information to the Office of Management and Budget for 
review and approval.
    Summary of Proposal(s):
    (1) Collection title: Request to Non-Railroad Employer for 
Information About Annuitant's Work and Earnings.
    (2) Form(s) submitted: RL-231-F.
    (3) OMB Number: 3220-0107.
    (4) Expiration date of current OMB clearance: 02/28/2006.
    (5) Type of request: Extension of a currently approved collection.
    (6) Respondents: Business or other for-profit.
    (7) Estimated annual number of respondents: 300.
    (8) Total annual responses: 300.
    (9) Total annual reporting hours: 150.
    (10) Collection description: Under the Railroad Retirement Act 
(RRA), benefits are not payable if an annuitant works for an employer 
covered under the RRA or last non-railroad employer. The collection 
obtains information regarding an annuitant's work and earnings from a 
non-railroad employer. The information will be used for determining 
whether benefits should be withheld.
    Additional Information or Comments: Copies of the forms and 
supporting documents can be obtained from Charles Mierzwa, the agency 
clearance officer (312-751-3363) or <a href="/cdn-cgi/l/email-protection#cd8ea5acbfa1a8bee380a4a8bfb7baac8dbfbfafe3aaa2bb"><span class="__cf_email__" data-cfemail="94d7fcf5e6f8f1e7bad9fdf1e6eee3f5d4e6e6f6baf3fbe2">[email protected]</span></a>.
    Comments regarding the information collection should be addressed 
to Ronald J. Hodapp, Railroad Retirement Board, 844 North Rush Street, 
Chicago, Illinois 60611-2092 or <a href="/cdn-cgi/l/email-protection#23714c4d424f470d6b4c47425353635151410d444c55"><span class="__cf_email__" data-cfemail="6b3904050a070f4523040f0a1b1b2b191909450c041d">[email protected]</span></a> and to the OMB 
Desk Officer for the RRB, at the Office of Management and Budget, Room 
10230, New Executive Office Building, Washington, DC 20503.

Charles Mierzwa,
Clearance Officer.
[FR Doc. 05-23475 Filed 11-29-05; 8:45 am]
BILLING CODE 7905-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 15.14






[Letterhead of DeGolyer and MacNaughton]
  Consent of Independent Consultant
  We consent to the reference to our firm in the form and context in which they appear in this Annual Report on Form 20-F of CNOOC Limited, the inclusion of our report dated February 27, 2014, herein, and to the incorporation by reference in any Registration Statement on Form F-3 and related Prospectus Supplements of CNOOC Limited for the registration of debt securities and guarantees previously filed with the Securities and Exchange Commission.
  
 /s/ DeGolyer and MacNaughtonDeGolyer and MacNaughtonTexas Registered Engineering Firm F-716
  Dallas, Texas
  April 10, 2014
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 1 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 2 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 3 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 4 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 5 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 6 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 7 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 8 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 9 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 10 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 11 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 12 of 13
Case 1:06-cv-14959-AKH Document 1 Filed 12/08/2006 Page 13 of 13
Exhibit 21.1
 LIST OF SUBSIDIARIES
 Name of Subsidiary
    
    Jurisdiction of Formation
    
    Doing Business AsVMdirect L.L.C.
    
    Nevada
    
    N/AVMdirect UK Ltd.
    
    England
    
    N/ADigitalFX Networks, LLC
    
    Nevada
    
    N/ADigitalFX Solutions, LLC
    
    Nevada
    
    N/ADigitalFX Europe, Ltd.
    
    Ireland
    
    N/ABlue Trident Enterprises, LLC
    
    New York
    
    N/A
#### STATE v. PASCHAL

No. 610P82.

Case below: 59 N.C. App. 239.

Petition by defendant for discretionary review under G.S. 7A-31 denied 8 March 1983.
Case 7:07-cv-03305-KMK-LMS Document 1-4 Filed 04/24/2007 Page 1 of 3
Case 7:07-cv-03305-KMK-LMS Document 1-4 Filed 04/24/2007 Page 2 of 3
Case 7:07-cv-03305-KMK-LMS Document 1-4 Filed 04/24/2007 Page 3 of 3
Exhibit 4.9


 


Amended and
Restated Power of Attorney


 


I,
Chen Guangqiang, with the ID number of 132903196307299817 , am a shareholder who owns a 90.37% equity
interest in Beijing Baihengda Petroleum Technology Co., Ltd. (" Petroleum Technology ") (" My
Equity "). Since my equity interest in the Power of Attorney dated January 1, 2008 has been effectively canceled, I
hereby irrevocably authorize Recon Hengda Technology (Beijing) Co., Ltd. ( " Hengda Technology ") to exercise
the following rights during the validity period of this power of attorney:


 


To
authorize Hengda Technology to act as my sole and exclusive agent to exercise all rights on my behalf in my name on matters related to
my equity, including but not limited to the following rights: (1) participate in the shareholders’ meeting of Petroleum Technology
and execute the relevant shareholders’ resolutions on my behalf; (2) exercise all the shareholder rights that I have in accordance
with the law and the articles of association of Petroleum Technology, including but not limited to shareholders’ voting rights,
the right to sell or transfer or pledge or dispose of all or any part of my equity; and (3) as my authorized representative, designate
and appoint the legal representative, chairman of the board, directors, supervisors, general manager and other senior management personnel
of Petroleum Technology.


 


Hengda Technology will have
the right to sign the revised and restated exclusive right of purchase contract (I shall be a party to the contract) on behalf of me within
the scope of authorization, and perform the assignment contract as a party to the contract on the same day as this power of attorney.
The exercise of the revised and restated equity pledge contract and the revised and restated exclusive right of purchase contract signed
will not impose any restriction on the exercise of this authorization.


 


Except as otherwise stipulated
in this power of attorney, all actions of Hengda Technology regarding my equity can be made in accordance with its own judgment without
any oral or written instructions from me.


 


All acts of Hengda
Technology regarding my equity shall be regarded as my own, and all signed documents shall be deemed to have been signed by me, and I
will recognize it.


 


Hengda Technology has the right
to delegate, and can re-delegate other individuals or units on its own for the handling of the above matters and the exercise of its own
equity without notifying me or obtaining my consent in advance, but it shall notify me immediately afterwards, and such delegated rights
The exercise shall not harm my interests.


 


While I am a shareholder of
Petroleum Technology, this power of attorney is irrevocable and continues to be valid, starting from the date of signing this power of
attorney.


 


During the period of this power
of attorney, if I need to exercise all the rights related to my equity that have been authorized to Hengda Technology through this power
of attorney, I shall negotiate with Hengda Technology.


 


 


	 	/s/ Chen Guangqiang
	 	Chen Guangqiang
	 	 
	 	 
	 	Effective as of April 1, 2019
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 17-1930

BRIEN O. HILL,

Plaintiff - Appellant,

v.

LEARNING EXPERIENCE,

Defendant - Appellee.

Appeal from the United States District Court for the Eastern District of Virginia, at 

Alexandria. Gerald Bruce Lee, District Judge. (1:15-cv-01593-GBL-TCB)

Submitted: October 17, 2017 Decided: October 19, 2017

Before FLOYD and HARRIS, Circuit Judges, and HAMILTON, Senior Circuit Judge.

Affirmed by unpublished per curiam opinion.

Brien O. Hill, Appellant Pro Se. Richard Maxwell Volin, VOLIN EMPLOYMENT 

LAW, PLLC, Falls Church, Virginia, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Brien O. Hill appeals the district court’s order granting summary judgment to The 

Learning Experience (“TLE”) on Hill’s disability discrimination claim. We have 

reviewed the record and find no reversible error. Accordingly, we affirm for the reasons 

stated by the district court. Hill v. Learning Experience, No. 1:15-cv-01593-GBL-TCB 

(E.D. Va. filed July 28, 2017 & entered July 31, 2017). We dispense with oral argument 

because the facts and legal contentions are adequately presented in the materials before 

this court and argument would not aid the decisional process.

AFFIRMED
Case 1:06-cv-14862-AKH Document 5 Filed 12/08/2006 Page 1 of 1
---

EXHIBIT 4.19

Global Medical Sciences Inc.
Letter of intent

August 28, 2002
Antonios Kripotos
President 
San Antonios Resources Inc.
Per:
Mr. Lindsay Semple
Suite 536-1489 Marine Drive
West Vancouver
British Columbia, V7T I B8
Sir:

This is to indicate our interest as licensors ("Licensor") to
enter into an exclusive worldwide licensing agreement with San Antonios
Resources Inc. ("GPM Inc.") (name to be changed to Global Precision Medical Inc
before closing) for the licencing of a technology known as the URO stent
technology (the "Technology").
The conditions under which we are prepared to enter into this transaction are
the following.
1. We will on Closing enter into a Technology Licence Agreement with GPM Inc.
providing for an exclusive worldwide licence to commercialize the Technology.
2. In consideration of such Licence Agreement, we shall be issued an equal
number of shares to the common shares which shall be on the books of the Company
at the date of closing, which we understand will be approximately 3,975,000. The
Licence Agreement shall provide that it shall, at our election, become null and
void in the event that GPM Inc. is found to have made a material
misrepresentation. A material misrepresentation shall include, without
limitation: (1) the existence of any undisclosed debt in excess of $25,000; (2)
the breach by GPM Inc. of any law leading to the payment of money or the
incurring of any obligation by GPM Inc. in excess of $25,000; (3) the failure to
comply or the breach of any securities law or requirement, and (4) any reason
preventing GPM Inc. from fully exploiting the Technology.
3. The Licence Agreement shall also provide us with the full opportunity to
conduct a due diligence on GPM Inc. before Closing, which shall include, without
limitation, access to all books and records. To this end, the Investor Group
shall send us within ten (10) business days of the present letter audited
financial statements of GPM Inc. for the past four (2) years as well as Canadian
and U.S. federal, provincial and state tax returns for such years with related
Notices of Assessment or Reassessment and the date of the last tax audits by
Canadian and U.S. federal, provincial and state authorities. This shall include
subsidiaries of GPM Inc..
4. Before Closing, the finance group shall have acquired or shall have the right
to acquire at least 2.800,000 of all existing issued shares of San Antonios
Resources Inc (publicly reported as being 3,073,129) that are issued and
outstanding.
The present letter is subject to our due diligence as to the referenced matters
above.
Signed this 28th day of August, 2002
GLOBAL MEDICAL SCIENCES INC.

Per:
/s/ Boris Weiss

Boris Weiss - President
SAN ANTONIOS RESOURCES INC.
/s/ Antonios Kripotos

Antonios Kripotos - President
Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 1 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 1 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 2 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 2 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 3 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 3 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 4 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 4 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 5 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 5 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 6 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 6 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 7 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 7 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 8 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 8 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 9 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 9 of 10

Case 1:07-cv-03496-WHP Document 36-14 Filed 07/11/2007 Page 10 of 10 Case 05-21207 Document 3656 Filed in TXSB on 01/26/2007 Page 10 of 10
Order issued November ,2012

In The

 fil! iztri i of exaa at allaa

No. 05-12-01428-CV

ENNIS REGIONAL MEDICAL CENTER, ET AL., Appellants

Ve

BRENDA CRENSHAW, INDIVIDUALLY AND AS NEXT FRIEND FOR MINORS

DEVEN COLLINS, JACOBIE COLLINS, AND LONNIE COLLINS, HI, Appellees

ORDER

We GRANT the November 12, 2012 unopposed motion for an extension of time to file a

brief filed by appellant, Texas Health Presbyterian Hospital Dallas. Appellant shall file its brief on

or before December 3, 2012.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                     Notice is hereby given of a change in the meeting of the National Institute of Environmental Health Sciences Special Emphasis Panel, November 15, 2005, 1 p.m. to November 15, 2005, 3:30 p.m. Nat. Inst. of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T.W. Alexander Drive, Research Triangle Park, NC, 27709 which was published in the                     **Federal Register**                     on October 24, 2005, FR 70 204 61464.                

The meeting will be held December 6, 2005 instead of November 15, 2005. The meeting is closed to the public.

Dated: November 2, 2005.

Anna Snouffer,

Acting Director, Office of Federal Advisory Committee Policy.

[FR Doc. 05-22481 Filed 11-9-05; 8:45am]

BILLING CODE 4140-01-M